• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S1 甲真菌病指南。

S1 Guideline onychomycosis.

机构信息

Labopart - Medizinische Laboratorien, Labor Leipzig-Mölbis [Labopart - Medical Laboratories, Laboratory Leipzig-Mölbis], Rötha OT Mölbis, Germany.

Praxis für Dermatologie [Dermatology practice], Hamburg, Germany.

出版信息

J Dtsch Dermatol Ges. 2023 Jun;21(6):678-692. doi: 10.1111/ddg.14988. Epub 2023 May 22.

DOI:10.1111/ddg.14988
PMID:37212291
Abstract

Onychomycosis is a fungal infection of the fingernails and toenails. In Europe, tinea unguium is mainly caused by dermatophytes. The diagnostic workup comprises microscopic examination, culture and/or molecular testing (nail scrapings). Local treatment with antifungal nail polish is recommended for mild or moderate nail infections. In case of moderate to severe onychomycosis, oral treatment is recommended (in the absence of contraindications). Treatment should consist of topical and systemic agents. The aim of this update of the German S1 guideline is to simplify the selection and implementation of appropriate diagnostics and treatment. The guideline was based on current international guidelines and the results of a literature review conducted by the experts of the guideline committee. This multidisciplinary committee consisted of representatives from the German Society of Dermatology (DDG), the German-Speaking Mycological Society (DMykG), the Association of German Dermatologists (BVDD), the German Society for Hygiene and Microbiology (DGHM), the German Society of Pediatric and Adolescent Medicine (DGKJ), the Working Group for Pediatric Dermatology (APD) and the German Society for Pediatric Infectious Diseases (DGPI). The Division of Evidence-based Medicine (dEBM) provided methodological assistance. The guideline was approved by the participating medical societies following a comprehensive internal and external review.

摘要

甲真菌病是指甲和趾甲的真菌感染。在欧洲,甲癣主要由皮肤癣菌引起。诊断包括显微镜检查、培养和/或分子检测(指甲刮屑)。对于轻度或中度的指甲感染,建议局部使用抗真菌指甲油治疗。对于中度至重度的甲真菌病,建议口服治疗(无禁忌症)。治疗应包括局部和全身药物。本德国 S1 指南更新的目的是简化适当诊断和治疗的选择和实施。该指南基于当前的国际指南和指南委员会专家进行的文献回顾的结果。该多学科委员会由德国皮肤病学会(DDG)、德语区真菌学会(DMykG)、德国皮肤科医生协会(BVDD)、德国卫生与微生物学会(DGHM)、德国儿科和青少年医学学会(DGKJ)、儿科皮肤病学工作组(APD)和德国儿科传染病学会(DGPI)的代表组成。循证医学司(dEBM)提供了方法学援助。该指南在经过全面的内部和外部审查后,得到了参与医学协会的批准。

相似文献

1
S1 Guideline onychomycosis.S1 甲真菌病指南。
J Dtsch Dermatol Ges. 2023 Jun;21(6):678-692. doi: 10.1111/ddg.14988. Epub 2023 May 22.
2
S1 guidelines: Tinea capitis.S1 指南:头癣。
J Dtsch Dermatol Ges. 2020 Feb;18(2):161-179. doi: 10.1111/ddg.14026.
3
[Tinea unguium--onychomycosis. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
Hautarzt. 1998 Oct;48 Suppl 1:S4-6.
4
[Antimycotic therapy of Tinea unguium and other onychomycoses].[甲癣及其他甲真菌病的抗真菌治疗]
Med Monatsschr Pharm. 2009 Aug;32(8):289-98; quiz 299-300.
5
Clinical Insights About Onychomycosis and Its Treatment: A Consensus.甲癣及其治疗的临床见解:一项共识。
J Drugs Dermatol. 2018 Mar 1;17(3):253-262.
6
Oral antifungal medication for toenail onychomycosis.用于治疗趾甲甲癣的口服抗真菌药物。
Cochrane Database Syst Rev. 2017 Jul 14;7(7):CD010031. doi: 10.1002/14651858.CD010031.pub2.
7
Pathogenic Dermatophytes Survive in Nail Lesions During Oral Terbinafine Treatment for Tinea Unguium.在口服特比萘芬治疗甲癣期间,致病性皮肤癣菌在指甲病变中存活。
Mycopathologia. 2017 Aug;182(7-8):673-679. doi: 10.1007/s11046-017-0118-8. Epub 2017 Mar 9.
8
[Clinical picture, causative agents and diagnostics of dermatomycoses].[皮肤真菌病的临床表现、病原体及诊断]
Dermatologie (Heidelb). 2022 Dec;74(12):974-993. doi: 10.1007/s00105-023-05245-z. Epub 2023 Oct 27.
9
Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure: S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM).德国卫生、环境医学与预防医学协会(GHUP)联合德国过敏症专科医生协会(AeDA)、德国皮肤病学会(DDG)、德国变态反应学与临床免疫学学会(DGAKI)、德国职业与环境医学学会(DGAUM)、德国医院卫生学会(DGKH)、德国肺病与呼吸医学学会(DGP)、德国真菌学会(DMykG)、儿科过敏症与环境医学学会(GPA)、德国联邦儿科学会(BAPP)以及奥地利医学真菌学会(ÖGMM)发布的室内霉菌暴露医学临床诊断AWMF指南简版:S2K指南
Allergo J Int. 2017;26(5):168-193. doi: 10.1007/s40629-017-0013-3. Epub 2017 Feb 28.
10
Tinea Unguium: Diagnosis and Treatment in Practice.甲真菌病:临床诊断与治疗。
Mycopathologia. 2017 Feb;182(1-2):95-100. doi: 10.1007/s11046-016-0078-4. Epub 2016 Oct 27.

引用本文的文献

1
Superficial Candidiasis: Cluster Analysis of Species Distribution and Their Antifungal Susceptibility In Vitro.浅部念珠菌病:菌种分布及其体外抗真菌药敏性的聚类分析
J Fungi (Basel). 2025 Apr 25;11(5):338. doi: 10.3390/jof11050338.
2
Onychomycosis Endonyx: A Systematic Review.甲内型甲癣:一项系统评价
Diseases. 2025 Apr 7;13(4):110. doi: 10.3390/diseases13040110.
3
Analysis of Causative Factors and Potential Predictors of Onychomycosis: A Retrospective Single-Center Study in Poland.甲癣的致病因素及潜在预测因素分析:波兰一项回顾性单中心研究
J Fungi (Basel). 2025 Feb 9;11(2):131. doi: 10.3390/jof11020131.
4
Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016-2022.美国甲癣的患者特征、诊断检测利用情况及抗真菌药物处方模式:一项使用DataDerm数据的队列研究,2016 - 2022年
Skin Appendage Disord. 2025 Feb;11(1):36-44. doi: 10.1159/000540704. Epub 2024 Aug 29.
5
Onychomycosis in the US Pediatric Population-An Emphasis on Fusarium Onychomycosis.美国儿科人群中的甲癣——重点关注镰刀菌性甲癣
Pediatr Dermatol. 2025 Jan-Feb;42(1):47-53. doi: 10.1111/pde.15785. Epub 2024 Oct 18.
6
Epidemiology of Onychomycosis in the United States Characterized Using Molecular Methods, 2015-2024.2015 - 2024年美国采用分子方法表征的甲癣流行病学
J Fungi (Basel). 2024 Sep 5;10(9):633. doi: 10.3390/jof10090633.
7
Photodynamic therapy in dermatology: established and new indications.皮肤科中的光动力疗法:既有适应症与新适应症
J Dtsch Dermatol Ges. 2024 Dec;22(12):1651-1662. doi: 10.1111/ddg.15464. Epub 2024 Sep 3.
8
Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.新抗真菌药物对日本甲真菌病处方和费用的影响:一项全国性索赔数据库研究。
J Dermatol. 2024 Sep;51(9):1172-1179. doi: 10.1111/1346-8138.17393. Epub 2024 Aug 8.
9
Fungal Melanonychia: A Systematic Review.真菌性甲黑线:一项系统评价。
Microorganisms. 2024 May 28;12(6):1096. doi: 10.3390/microorganisms12061096.
10
Case Report: Itraconazole Oral Solution Continuous Therapy for Infantile Tinea Capitis.病例报告:伊曲康唑口服液连续疗法治疗婴幼儿头癣。
Am J Trop Med Hyg. 2024 Mar 26;110(5):965-967. doi: 10.4269/ajtmh.23-0741. Print 2024 May 1.